Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13B |
| 2 |
Eaton
ETN
|
+$1.11B |
| 3 |
Analog Devices
ADI
|
+$867M |
| 4 |
Progressive
PGR
|
+$792M |
| 5 |
Datadog
DDOG
|
+$693M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.7B |
| 2 |
NVIDIA
NVDA
|
+$1.45B |
| 3 |
Salesforce
CRM
|
+$1.22B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 5 |
lululemon athletica
LULU
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Lennar Class A
LEN
$20.8B
| $53.3M | 0.03% |
367,517
+4,791
| +1% | +$729K |
|
202
Chesapeake Utilities
CPK
$3.2B
| $53.2M | 0.03% |
501,361
+72,527
| +17% | +$7.77M |
|
203
Acadia Healthcare
ACHC
$2.66B
| $53.2M | 0.03% |
787,157
-295,653
| -27% | -$20.6M |
|
204
Watsco Inc
WSO
$12.8B
| $52.2M | 0.03% |
112,689
-72,944
| -39% | -$33.3M |
|
205
Cognex
CGNX
$10.2B
| $51.8M | 0.03% |
1,107,545
+236,723
| +27% | +$10.4M |
|
206
Plains GP Holdings
PAGP
$5.54B
| $51.3M | 0.03% |
2,727,290
-76,613
| -3% | -$1.41M |
|
207
MACOM Technology Solutions
MTSI
$20.3B
| $51.1M | 0.03% |
458,694
+137,297
| +43% | +$14M |
|
208
MakeMyTrip
MMYT
$5.55B
| $50.9M | 0.03% |
605,799
-229,700
| -27% | -$17.2M |
|
209
Urban Edge Properties
UE
$2.7B
| $50.8M | 0.03% |
2,750,150
+743,235
| +37% | +$12.8M |
|
210
Expro Ltd
XPRO
$1.98B
| $50.3M | 0.03% |
2,194,220
+1,371,971
| +167% | +$28.4M |
|
211
Johnson Controls International
JCI
$84.6B
| $50.2M | 0.03% |
755,484
+3,041
| +0.4% | +$205K |
|
212
Insmed
INSM
$25.9B
| $49.9M | 0.03% |
744,280
+625,768
| +528% | +$24.3M |
|
213
Eastern Bankshares
EBC
$5.09B
| $49M | 0.03% |
3,501,895
+508,587
| +17% | +$6.76M |
|
214
Marvell Technology
MRVL
$195B
| $48.5M | 0.03% |
694,044
+4,222
| +0.6% | +$296K |
|
215
Cactus
WHD
$4.86B
| $48.2M | 0.03% |
914,311
-208,477
| -19% | -$10.6M |
|
216
Zurn Elkay Water Solutions
ZWS
$7.97B
| $47.6M | 0.03% |
1,619,823
+344,530
| +27% | +$10.9M |
|
217
Take-Two Interactive
TTWO
$44B
| $47.2M | 0.03% |
303,847
-16,001
| -5% | -$2.43M |
|
218
Dyne Therapeutics
DYN
$4.68B
| $46.8M | 0.03% |
1,327,222
+119,671
| +10% | +$3.48M |
|
219
Agilent Technologies
A
$43.4B
| $46.5M | 0.03% |
359,008
+50,584
| +16% | +$7.07M |
|
|
NARI
220
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $46.5M | 0.03% |
966,173
+622,734
| +181% | +$27.6M |
|
221
Thermo Fisher Scientific
TMO
$230B
| $46.5M | 0.03% |
84,071
+535
| +0.6% | +$306K |
|
222
Skyward Specialty Insurance
SKWD
$2.36B
| $46.4M | 0.03% |
1,283,517
+473,080
| +58% | +$17.2M |
|
223
Brunswick
BC
$4.97B
| $45.4M | 0.03% |
624,248
-224,480
| -26% | -$18.3M |
|
224
RTX Corp
RTX
$285B
| $45.3M | 0.03% |
451,457
-6
| -0% | -$620 |
|
225
nVent Electric
NVT
$24B
| $45M | 0.03% |
586,753
+284,581
| +94% | +$22.1M |
|
Similar funds
Jennison Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Jennison Associates held 620 positions worth $156B, up 4.3% from $150B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates's Q2 2024 filing shows 48 new, 288 increased, 229 reduced and 48 closed positions. Its largest new stake was Analog Devices: 4,062,204 shares worth $927M. The largest sale was UnitedHealth, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2024 buy was Analog Devices: 4,062,204 shares worth $927M.
- Jennison Associates added most to Apple in Q2 2024, an estimated $2.13B increase.
- Jennison Associates's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.7B.
- Jennison Associates fully exited Estee Lauder in Q2 2024, selling an estimated $291M.
- Jennison Associates's ten largest holdings make up 48% of its $156B portfolio in Q2 2024.
- Jennison Associates opened 48 new positions and closed 48 in Q2 2024.
- Jennison Associates's portfolio value rose 4.3% quarter-over-quarter to $156B.
Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.